Is a complete BEAM research report available?

No complete published report is available for Beam Therapeutics Inc. (BEAM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Beam Therapeutics Inc. (BEAM)

NASDAQ: BEAM · USD

$28.9

+3.95 (+15.9%)· Recorded snapshot

Market cap	2.9B
Revenue (ttm)	156M
Net income (ttm)	-86.5M
EPS (ttm)	-$0.84
Shares out	99.9M
Volume	4,396,320
Beta	2.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 156M
Net income (ttm): -86.5M
EPS (ttm): -$0.84
Market cap: 2.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001745999
Company name	Beam Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	07373V105
Earnings date	2026-11-10
Earnings time	bmo
Employees	540
Employees change	31
Employees growth	6.09%
Enterprise value	$2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-02-06
Is primary listing	Yes
Is SPAC	No
ISIN number	US07373V1052
Last 10-K release date	2026-02-24
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.9B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$28.85
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	BEAM
U.S. state	Massachusetts
Website	https://beamtx.com

Metric

Value

Amount currency

USD

CIK code

0001745999

Company name

Beam Therapeutics Inc.

Country

United States

Country code

CUSIP number

07373V105

Earnings date

2026-11-10

Earnings time

bmo

Employees

540

Employees change

Employees growth

6.09%

Enterprise value

$2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-02-06

Is primary listing

Yes

Is SPAC

ISIN number

US07373V1052

Last 10-K release date

2026-02-24

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.9B

Market cap category

Mid-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$28.85

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

BEAM

U.S. state

Massachusetts

Website

https://beamtx.com

Metric	Value
Earnings yield	-2.9%
EV/Sales	10.78x
FCF / EV yield	-22.16%
FCF yield	-14.4%
Forward EV/Sales	33.65x
Forward P/S	51.76x
P/B ratio	2.33x
P/S ratio	16.59x
Price / tangible book value	2.42x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-2.9%

EV/Sales

10.78x

FCF / EV yield

-22.16%

FCF yield

-14.4%

Forward EV/Sales

33.65x

Forward P/S

51.76x

P/B ratio

2.33x

P/S ratio

16.59x

Price / tangible book value

2.42x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-242.27%
EBITDA margin	-228.01%
Gross margin	-161.91%
Operating margin	-242.27%
Pretax margin	-55.45%
Profit margin	-55.45%
Profit per employee	$-160,222
Revenue per employee	$288,954
ROA	-17.01%
ROA (5Y)	-15.43%
ROCE	-28.96%
ROE	-8.18%
ROE (5Y)	-34.74%
ROIC	-18.78%
SBC / revenue	52.24%

Metric

Value

EBIT margin

-242.27%

EBITDA margin

-228.01%

Gross margin

-161.91%

Operating margin

-242.27%

Pretax margin

-55.45%

Profit margin

-55.45%

Profit per employee

$-160,222

Revenue per employee

$288,954

ROA

-17.01%

ROA (5Y)

-15.43%

ROCE

-28.96%

ROE

-8.18%

ROE (5Y)

-34.74%

ROIC

-18.78%

SBC / revenue

52.24%

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	158.89%
Revenue growth (Q)	-94.21%
Revenue growth (QoQ)	-98.46%
Revenue growth 3Y	24.86%
Revenue growth 5Y	478.9%
Revenue growth years	1

Metric

Value

EPS growth years

Net income growth years

Revenue growth

158.89%

Revenue growth (Q)

-94.21%

Revenue growth (QoQ)

-98.46%

Revenue growth 3Y

24.86%

Revenue growth 5Y

478.9%

Revenue growth years

Metric	Value
Capital expenditures	$-13.4M
Depreciation and amortization	$22.2M
EBIT	$-378M
EBITDA	$-355.8M
EPS	$-0.84
FCF per share	$-3.73
Financing cash flow	$107.7M
Free cash flow	$-372.8M
Free cash flow minus SBC	$-454.3M
Gross profit	$-252.6M
Investing cash flow	$189.5M
Net borrowing	$93.9M
Net cash flow	$-62.2M
Net income	$-86.5M
Operating cash flow minus SBC	$-440.9M
Operating income	$-378M
Revenue	$156M
Stock-based compensation	$81.5M

Metric

Value

Capital expenditures

$-13.4M

Depreciation and amortization

$22.2M

EBIT

$-378M

EBITDA

$-355.8M

EPS

$-0.84

FCF per share

$-3.73

Financing cash flow

$107.7M

Free cash flow

$-372.8M

Free cash flow minus SBC

$-454.3M

Gross profit

$-252.6M

Investing cash flow

$189.5M

Net borrowing

$93.9M

Net cash flow

$-62.2M

Net income

$-86.5M

Operating cash flow minus SBC

$-440.9M

Operating income

$-378M

Revenue

$156M

Stock-based compensation

$81.5M

Metric	Value
Altman Z-Score	3.08
Book value per share	$10.68
Debt / equity	0.23
Long-term assets	$207.8M
Long-term liabilities	$238M
Net cash (debt)	$905.6M
Net cash / market cap	34.99%
Net cash growth	-9.04%
Net debt / equity	-0.85
Piotroski F-Score	3
Property, plant and equipment	$193.2M
Shareholders' equity	$1.1B
Tangible book value	$1.1B
Tangible book value per share	$10.68
Total assets	$1.4B
Total cash	$1.2B
Total debt	$247.4M
Total liabilities	$318.9M
WACC	14.93%

Metric

Value

Altman Z-Score

3.08

Book value per share

$10.68

Debt / equity

0.23

Long-term assets

$207.8M

Long-term liabilities

$238M

Net cash (debt)

$905.6M

Net cash / market cap

34.99%

Net cash growth

-9.04%

Net debt / equity

-0.85

Piotroski F-Score

Property, plant and equipment

$193.2M

Shareholders' equity

$1.1B

Tangible book value

$1.1B

Tangible book value per share

$10.68

Total assets

$1.4B

Total cash

$1.2B

Total debt

$247.4M

Total liabilities

$318.9M

WACC

14.93%

Metric	Value
Asset turnover	0.11
Current assets	$1.2B
Current liabilities	$80.9M
Current ratio	14.57
Net working capital	$-40M
Quick ratio	14.25
Working capital	$1.1B
Working capital turnover	0.15

Metric

Value

Asset turnover

0.11

Current assets

$1.2B

Current liabilities

$80.9M

Current ratio

14.57

Net working capital

$-40M

Quick ratio

14.25

Working capital

$1.1B

Working capital turnover

0.15

Metric	Value
Buyback yield / dilution	-16.29%
Dividend yield	0%
Shareholder yield	-16.29%

Metric

Value

Buyback yield / dilution

-16.29%

Dividend yield

Shareholder yield

-16.29%

Metric	Value
150-day SMA	$28.27
1D price change	15.86%
1M price change	17.18%
1M total return	17.18%
1W price change	14.08%
1W total return	14.08%
1Y price change	6.4%
1Y return CAGR	6.4%
1Y total return	6.4%
20-day SMA	$24.80
200-day SMA	$28.21
3M price change	13.44%
3M total return	13.44%
3Y price change	52.74%
3Y return CAGR	15.16%
3Y total return	52.74%
50-day SMA	$25.95
50-day SMA vs 200-day SMA	50under200
52-week high	$38.26
52-week high date	2026-07-07
52-week low	$20.23
52-week low date	2025-11-20
5Y price change	-69.02%
5Y return CAGR	-20.89%
5Y total return	-69.02%
6M price change	-2.49%
6M total return	-2.49%
All-time high	$138.52
All-time high date	2021-07-02
All-time low	$13.00
All-time low date	2020-03-16
Average true range (ATR)	$1.50
Average volume	1.9M
Beta (1Y)	2.83
Beta (2Y)	2.32
Beta (5Y)	2.2
Change from 52-week high	-24.59%
Change from 52-week low	42.61%
Change from all-time high	-79.47%
Change from all-time low	118.77%
Change from open	16.66%
Day's gap	-0.68%
Dollar volume	$126.8M
High price	$28.86
Low price	$24.56
Monthly RSI	51.11
Open price	$24.73
Position in 52-week range	99.77%
Premarket change	0.84%
Premarket close	$24.90
Premarket price	$25.11
Premarket volume	15K
Previous close	$24.90
Price vs 150-day SMA	0.59%
Price vs 20-day SMA	14.69%
Price vs 200-day SMA	0.83%
Price vs 50-day SMA	9.6%
Relative volume	2.36
Return from IPO open	7.92%
Return from IPO price	52.35%
RSI	65.44
Sharpe ratio	0.38
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	-0
Sortino ratio	0.7
Sortino ratio (3Y)	0.87
Sortino ratio (5Y)	0.08
Volume	4.4M
Weekly RSI	53.02
YTD price change	2.6%
YTD total return	2.6%

Metric

Value

150-day SMA

$28.27

1D price change

15.86%

1M price change

17.18%

1M total return

17.18%

1W price change

14.08%

1W total return

14.08%

1Y price change

6.4%

1Y return CAGR

6.4%

1Y total return

6.4%

20-day SMA

$24.80

200-day SMA

$28.21

3M price change

13.44%

3M total return

13.44%

3Y price change

52.74%

3Y return CAGR

15.16%

3Y total return

52.74%

50-day SMA

$25.95

50-day SMA vs 200-day SMA

50under200

52-week high

$38.26

52-week high date

2026-07-07

52-week low

$20.23

52-week low date

2025-11-20

5Y price change

-69.02%

5Y return CAGR

-20.89%

5Y total return

-69.02%

6M price change

-2.49%

6M total return

-2.49%

All-time high

$138.52

All-time high date

2021-07-02

All-time low

$13.00

All-time low date

2020-03-16

Average true range (ATR)

$1.50

Average volume

1.9M

Beta (1Y)

2.83

Beta (2Y)

2.32

Beta (5Y)

2.2

Change from 52-week high

-24.59%

Change from 52-week low

42.61%

Change from all-time high

-79.47%

Change from all-time low

118.77%

Change from open

16.66%

Day's gap

-0.68%

Dollar volume

$126.8M

High price

$28.86

Low price

$24.56

Monthly RSI

51.11

Open price

$24.73

Position in 52-week range

99.77%

Premarket change

0.84%

Premarket close

$24.90

Premarket price

$25.11

Premarket volume

15K

Previous close

$24.90

Price vs 150-day SMA

0.59%

Price vs 20-day SMA

14.69%

Price vs 200-day SMA

0.83%

Price vs 50-day SMA

9.6%

Relative volume

2.36

Return from IPO open

7.92%

Return from IPO price

52.35%

RSI

65.44

Sharpe ratio

0.38

Sharpe ratio (3Y)

0.49

Sharpe ratio (5Y)

-0

Sortino ratio

0.7

Sortino ratio (3Y)

0.87

Sortino ratio (5Y)

0.08

Volume

4.4M

Weekly RSI

53.02

YTD price change

2.6%

YTD total return

2.6%

Metric	Value
Float	88.3M
Float percentage	88.4%
Shares change (QoQ)	1.03%
Shares change (YoY)	16.29%
Shares held by insiders	1.36%
Shares held by institutions	96.56%
Shares outstanding	99.9M
Short % of float	29.71%
Short % of shares	26.26%
Short ratio	14.3 days

Metric

Value

Float

88.3M

Float percentage

88.4%

Shares change (QoQ)

1.03%

Shares change (YoY)

16.29%

Shares held by insiders

1.36%

Shares held by institutions

96.56%

Shares outstanding

99.9M

Short % of float

29.71%

Short % of shares

26.26%

Short ratio

14.3 days

Beam Therapeutics Inc. (BEAM)

Price

Financial snapshot

Fair-value bridge

Latest news · BEAM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BEAM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BEAM

Frequently asked questions